(Q40265040)

19 September 2017

title

Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines (English)

1 reference

human subject research project

19 September 2017

0 references

0 references

1 reference

12

1 reference

19 September 2017

2

Kenneth H Eckels

1 reference

19 September 2017

Wellington Sun

1

1 reference

19 September 2017

J Robert Putnak

3

1 reference

19 September 2017

Arthur G Lyons

4

1 reference

19 September 2017

Stephen J Thomas

5

1 reference

19 September 2017

David W Vaughn

6

1 reference

19 September 2017

Robert V Gibbons

7

1 reference

19 September 2017

Stefan Fernandez

8

1 reference

19 September 2017

Vicky J Gunther

9

1 reference

19 September 2017

Mammen P Mammen

10

1 reference

19 September 2017

John D Statler

11

1 reference

19 September 2017

language of work or name

English

0 references

publication date

5 December 2012

1 reference

Journal of Infectious Diseases

19 September 2017

published in

1 reference

19 September 2017

volume

207

1 reference

19 September 2017

issue

5

1 reference

19 September 2017

page(s)

700-708

1 reference

The dengue threat to the United States

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Towards a global dengue research agenda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Pathogenesis of dengue: challenges to molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Progress towards a dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Vaccines against dengue: a review of current candidate vaccines at advanced development stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

A new quantitative RT-PCR method for sensitive detection of dengue virus in serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Sonographic findings of healthy volunteers infected with dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Early clinical and biological features of severe clinical manifestations of dengue in Vietnamese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS744

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIS744

1 reference

19 September 2017

1 reference